Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer
Condition: Endometrial Cancer Intervention: Drug: anlotinib and anti PD-1 antibody Sponsor: Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials